Non-Surgical Treatment of Uterine Fibroids. Efficacy of the Selective Progesterone Receptor Modulator

Medical Council
doi 10.21518/2079-701x-2019-7-13-20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.

Related search

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids With a Focus on Ulipristal Acetate

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

The Past, Present, and Future of Selective Progesterone Receptor Modulators in the Management of Uterine Fibroids

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2018English

Treatment of Uterine Fibroids.

JAMA - Journal of the American Medical Association
Medicine
1893English

Treatment of Uterine Fibroids.

The Lancet
Medicine
1924English

Efficacy and Safety of the Selective Progesterone Receptor Modulator (PRM) Vilaprisan - 24-Week Outcomes From Asteroid 2

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Reproductive Outcomes Following Surgical Removal of Uterine Fibroids

Medical Council
2019English

Alternatives to Hysterectomy for Treatment of Uterine Fibroids

The Obstetrician & Gynaecologist
2004English

Role of Uterine Artery Embolisation in the Treatment of Symptomatic Fibroids

International Journal of Advances in Medicine
2017English

The Surgical Treatment of Uterine Myoma

BMJ
1890English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy